Gilead Sciences (GILD): 'Acquisition Wanted! - Please Apply Within'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
Gilead Sciences Announces 10 Percent Increase in First Quarter 2017 Dividend
February 7, 2017 4:02 PM ESTFOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Board of Directors declared an increase of 10% in the companys quarterly cash dividend, beginning in the first quarter of 2017. The dividend increase will result in a quarterly... More
Gilead Sciences Announces Fourth Quarter and Full Year 2016 Financial Results
February 7, 2017 4:01 PM EST- Fourth Quarter Product Sales of $7.2 billion -
- Full Year 2016 Product Sales of $30.0 billion -
- Full Year 2016 Diluted EPS of $9.94 per share -
- Full Year 2016 Non-GAAP Diluted EPS of $11.57 per share -
FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2016. Total revenues for the fourth quarter of 2016 were $7.3 billion, compared to $8.5 billion... More
